DBA News 26.46 09/02/2014 04:39:50 Powershares DB Agriculture

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Powershares DB Agriculture Fund (DBA) 26.46 $DBA

Is the Incredible Run in Coffee ETFs Finally Over? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 9:00AM CDT
Why coffee ETFs might be due for some trouble in the weeks ahead.

Watch for PowerShares DB Agriculture Fund to Potentially Rebound After Falling 1.40% Yesterday
Comtex SmarTrend(R) - Tue Aug 12, 5:28PM CDT
PowerShares DB Agriculture Fund (NYSEBA) traded in a range yesterday that spanned from a low of $26.03 to a high of $26.28. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $26.11 on volume of 695,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

PowerShares DB Agriculture Fund Set to Possibly Rebound After Yesterday's Selloff of 1.40%
Comtex SmarTrend(R) - Tue Aug 12, 5:28PM CDT
PowerShares DB Agriculture Fund (NYSEBA) traded in a range yesterday that spanned from a low of $26.03 to a high of $26.28. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $26.11 on volume of 695,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Russian Food Import Ban Takes a Bite Out of These Agricultural ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Aug 11, 11:00AM CDT
Watch these commodity ETFs after Russia announced a food import ban from the West.
1 Comment

Cotton ETFs in Focus as Crash Continues - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 7:00AM CDT
Behind the slump in cotton prices and cotton ETFs as prices hit two year lows.

First Week of DBA August 16th Options Trading
DividendChannel.com - Tue Jul 01, 9:44AM CDT
Investors in DB Agriculture Fund saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DBA options chain for the new August 16th contracts and...

Global X Plans Emerging Market Bond, Commodity ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 7:00AM CDT
Global X is putting more funds into the pipeline, looking to add products in the emerging market bond and commodity ETF segments.

Inside The Top Ranked Corn ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 7:00AM CDT
Why the corn ETF could be an interesting play for investors right now.

PowerShares DB Agriculture Fund Shares Up 11.1% Since SmarTrend's Buy Recommendation (DBA)
Comtex SmarTrend(R) - Fri Mar 28, 9:36AM CDT
SmarTrend identified an Uptrend for PowerShares DB Agriculture Fund (NYSEBA) on February 14th, 2014 at $25.56. In approximately 1 month, PowerShares DB Agriculture Fund has returned 11.13% as of today's recent price of $28.40.

Wheat ETF Surging on Ukraine Issues, Weather Outlook - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 9:00AM CDT
Can the Wheat ETF (WEAT) from Teucrium be an interesting choice for investors right now?

PowerShares DB Agriculture Fund Has Returned 12.3% Since SmarTrend Recommendation (DBA)
Comtex SmarTrend(R) - Wed Mar 19, 11:25AM CDT
SmarTrend identified an Uptrend for PowerShares DB Agriculture Fund (NYSEBA) on February 14th, 2014 at $25.56. In approximately 1 month, PowerShares DB Agriculture Fund has returned 12.27% as of today's recent price of $28.69.

4 Agricultural Commodity ETFs Soaring in 2014 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 17, 7:03AM CDT
These commodity ETFs have all added more than 10 percent in the past one month time frame.

4 Commodity ETFs Leading the Surge - Video Blog
Eric Dutram - Zacks Investment Research - Thu Mar 13, 4:05PM CDT
These Commodity ETFs have added more than 10% in the past month.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 0

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 177

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Gayatri Pariwar Celebrates 100 Years with Massive Yoga Event

Updated Category News Views 52

An Impressive Centenary for Gayatri Pariwar Sometimes, you get hit by a wave so big you can't ignore it, and Gayatri Pariwar's centennial festival in New Delhi was one such tsunami. Picture this: countless souls gathered to mark a hundred years of spiritual and social reform, not just with chants and talks, but through an awe-inspiring mass yoga event. In my decades...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 231

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 459

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 23

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 54

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 46

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 373

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 142

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading

Top 5 Most Recently Viewed Articles

Insigneo Welcomes Esteban Diaz to Enhance Wealth Management

Updated Category News Views 159

Insigneo Strengthens Its Wealth Management Team Insigneo, a prominent name in wealth management, proudly announces the addition of Esteban Diaz as Senior Vice President. This significant recruitment is part of the firm’s ongoing commitment to enhancing its network, particularly in serving high-net-worth clients in the Latin American region. About Esteban Diaz's...

Continue Reading
Exploring RBC Bearings: A Five-Year Investment Journey

Updated Category News Views 172

RBC Bearings: A Strong Investment Over Time RBC Bearings has proven to be a formidable player in the market, showcasing impressive performance over the last five years. With an average annual return of 18.74%, any investment made during this period would have reaped considerable rewards. The Growth of a $1000 Investment Imagine if you had decided to invest $1000 in RBC...

Continue Reading
ANI Pharmaceuticals Enhances Ophthalmology Strategy with Experts

Updated Category News Views 227

ANI Pharmaceuticals Launches FutureVision Advisory Council In a strategic move to bolster its ophthalmology and retina franchise, ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) has established the FutureVision Advisory Council. This dedicated council aims to guide the ongoing innovations within ANI's Rare Disease portfolio, focusing particularly on ophthalmological care....

Continue Reading
Unlocking Financial Freedom: The CESUR Mining Game Changer

Updated Category News Views 99

Understanding CESUR Mining and Its Impact CESUR Mining is quickly becoming a significant player in the world of cryptocurrency. This innovative platform enables users to tap into the potential of cloud mining, allowing them to earn passive income without the need for technical knowledge or constant monitoring. Established with the vision to simplify the mining process,...

Continue Reading
Understanding Nvidia's Role in the S&P 500 Market Dynamics

Updated Category News Views 204

Nvidia's Influence on the S&P 500 Market The stock market can be quite a wild ride, with swings that can astonish even the most experienced investors. Recently, stocks started off relatively flat but soon encountered volatility, leading to a significant rally largely fueled by news surrounding Nvidia. This surge prompts important questions about how the S&P 500 will...

Continue Reading